tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
Advertisement

Tvardi Therapeutics (TVRD) Similar Stocks

Compare
2,538 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
$3.94
$41.17M
-0.25
-64.85%
3 Buy
4 Hold
0 Sell
Moderate Buy
Plus Therapeutics
$0.58
$74.89M
-62.28%
4 Buy
0 Hold
0 Sell
Strong Buy
Cue Biopharma
$0.72
$55.42M
-1.31
-56.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Aligos Therapeutics
$7.10
$44.35M
-0.36
-24.06%
1 Buy
0 Hold
0 Sell
Moderate Buy
Genenta Science SpA Sponsored ADR
$2.29
$44.04M
-4.50
-53.27%
1 Buy
0 Hold
0 Sell
Moderate Buy
Adlai Nortye Ltd. Sponsored ADR
$1.64
$53.51M
-31.72%
0 Buy
1 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVRD
Tvardi Therapeutics
3.94
-8.30
-67.81%
PSTV
Plus Therapeutics
0.51
-0.72
-58.54%
CUE
Cue Biopharma
0.72
-1.00
-58.14%
ALGS
Aligos Therapeutics
7.10
-3.09
-30.32%
GNTA
Genenta Science SpA Sponsored ADR
2.29
-2.61
-53.27%
ANL
Adlai Nortye Ltd. Sponsored ADR
1.55
-1.99
-56.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis